drugset / Trial / NCT03024944

TAU PET Imaging in Northern Manhattan Study of Metabolism and Mind

NCT03024944

NaSingle-groupOpen-labelDiagnostic

Summary

The purpose of this project is to study brain imaging of a substance called tau, which is found in brains of persons with Alzheimer's disease, using the Tau binder, 18F-THK-5351, for live imaging of tau in the brain. The main goal of this proposal is to study whether diabetes status (type 2 diabetes \[referred to as diabetes\] and pre-diabetes, compared with normal glucose tolerance \[NGT\]), is associated with increased tau accumulation in the brain, one of the culprits of Alzheimer's disease, in a community-based group of middle aged Caribbean-Hispanics with a mean age of 63 years. The investigators propose to conduct tau positron emission tomography (PET) imaging in 30 middle aged Hispanics.

Timeline

Start
2017-12
Primary completion
2019-01
Completion
2020-01

Drugs

EvaluationDrugModalityDoseRoute
Subject [18F]THK-5351 Diagnostic / imaging agent Intravenous